PATH, Coalition for Access to NCD Medicines and Products
Advancing access and financing for NCD medicines and products | UNGA80 Event Action Report
Report
20 Oct 2025
The Role of Health Technology Assessment in Medicine Pricing and Reimbursement
Health Action International (HAI)
27 Nov 2018
This policy brief summarises the key points from the review on the role of health technology assessment (HTA) in medicine pricing and reimbursement with a focus on its use in low- and middle-income countries (LMICs).
Related Resources
Union for International Cancer Control (UICC)
Policy Brief: Strengthening Equitable Access to Breast Cancer Care through National Health Policies
Briefs & Fact Sheets
13 Oct 2025
World Health Organization
Global report on hypertension 2025: high stakes: turning evidence into action
Report
23 Sep 2025
European Lung Foundation
Living with chronic respiratory disease: voices from around the world
Briefs & Fact Sheets
23 Sep 2025
PATH, Coalition for Access to NCD Medicines and Products
The case for investing better in noncommunicable diseases - even in times of crisis
Briefs & Fact Sheets
22 Sep 2025
Lancet Respiratory Medicine
Global epidemiology of chronic respiratory disease
Publication
22 Sep 2025